Integrium Clinical Research will be attending the Rodman & Renshaw 17th Annual Global Investment Conference and hopes to meet with healthcare professionals to discuss clinical synergies and capital raising for biotechs. Of the 3,000 attendees anticipated, growth companies and financial and strategic investors are being brought together to build 'revenue-generating relationships'. The focus of the conference will be dedicated to tracks on Healthcare, Metals & Mining, Technology, Cleantech and Growth, providing an opportunity for 300 public and private companies to present their businesses. Also on the agenda is Keynote Speaker: Henry A. Kissenger, 56th United States Secretary of State and Nobel Peace Laureate. With a combined 31+ year conference track record, Rodman & Renshaw and H.C. Wainwright & Co., sponsoring the 17th Annual Conference, are sure to bring forward another renowned atmosphere of networking, marketing, and corporate exposure.

Integrium understands without the appropriate resources, conceptualizing, funding, and growing an early-stage biotech can become a challenge. Through a trusted partnership with PoC Capital, Integrium is now able to help Micro Cap, Small Cap and Privately held Biotechs looking to raise additional rounds of financing, by providing new clinical data, to create the next bump in valuation. Integrium areas of therapeutic specialization include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases.